A group of hospitals in New Hampshire has pledged $50 million over five years to help fund opioid addiction treatment programs, a big boost in the state with the country’s third largest rate of drug overdoses.
Mice who were addicted to alcohol and were injected with human stem cells cut down their voluntary consumption by 80 to 90 percent in a new study conducted at the University of Chile.
Narcan, a drug used to reverse opioid overdoses, is “like an EpiPen or CPR” and anyone who has a loved one at risk should carry it and be trained to use it, according to the U.S. Surgeon General.
A pilot program in Virginia is offering free Uber rides to and from outpatient addiction centers and pharmacies, eliminating a barrier to treatment for poorer people in a rural area without mass-transit options.
The company that makes Suboxone and Sublocade has agreed to a $294 million deal for rights to a new drug that could help eliminate cravings for a wide variety of substances, including opioids, alcohol, and tobacco.
Lawmakers in seven states – Kentucky, Minnesota, New Jersey, New York, Tennessee, Vermont, and West Virginia – are considering proposals to tax opioid drugs, in some cases specifically to raise funds for addiction treatment programs.
A non-psychoactive substance found in the marijuana plant has proven effective at reducing relapse tendencies in rats, suggesting the possibility of a new and effective treatment drug.
A pilot program that pairs pregnant women who have a substance use disorder with a recovery coach who has also experienced addiction while pregnant has been launched by a non-profit organization in Madison, Wisconsin.
Addiction “is not a moral issue," according to Secretary of Health and Human Services Alex Azar, who says drug dependence should not be stigmatized and should be treated as a medical condition, not a personal weakness or moral fault.
Philadelphia police are now being given the choice of connecting addicts to social services instead of arresting them for drug possession, prostitution, and similar crimes.
Opioid deaths in England and Wales are up more than 50% in the last four years, sparking fears that the problem there could reach levels comparable to those in the U.S.
Larry Kudlow, President Trump’s choice as director of the National Economic Council, has been in recovery for 23 years from cocaine and alcohol and advocates increased government spending on rehab programs.
The federal judge in charge of more than 400 lawsuits by cities, counties, and Native American tribes over the opioid crisis is pushing for a settlement by the end of the year that will involve not just money but a meaningful solution to the problem.
The opioid death rate among African-Americans in urban areas is rising much faster than the comparable rate for white people, according to the U.S. Centers for Disease Control and Prevention.
Delaware, Illinois, Indiana, Maine, Missouri, Nevada, North Carolina, Ohio, Pennsylvania, and Wisconsin all had sharp increases in opioid overdoses from July 2016 through September 2017, according to a new survey of hospital data. Only one state – Kentucky – saw a significant decrease.
New York State has announced an additional $1.6 million in funding for mobile addiction treatment – vans that provide treatment space for people with transportation problems or shuttle them back and forth to treatment centers.
Only 10% of people who need opioid addiction treatment in Oklahoma currently receive it, according to a state commission report, and on a typical day there are 600 to 800 people on the state’s waiting list for inpatient services.
The World Health Organization has recognized “gaming disorder” – compulsively playing videogames on the Internet – as an addiction-like mental health condition, putting it in direct conflict with the American Psychiatric Association.
New York State has begun allowing hospitals that aren’t certified to provide detox services to provide them anyway, saying it’s better to treat addicts immediately rather than force them to wait for space in a more highly qualified facility.
A drug that was created by Eli Lilly and Co. to treat osteoarthritis – and that didn’t work – could prevent tolerance in opioid users and help relieve withdrawal symptoms, scientists say.